Sotagliflozin
Sotagliflozin (LP-802034) is a dual SGLT1 and SGLT2 inhibitor with oral bioavailability, investigated for its antihyperglycemic potential. It is used in research on diabetes and heart failure, with studies demonstrating its effects on glucose homeostasis in both in vitro assays and in vivo models.
Product Specifications
CAS Number
1018899-04-1
Product Name Alternative
Inhibitor, LP802034, LP-802034, LP 802034, inhibit, LX4211, LX-4211, LX 4211, SGLT1, SGLT2, SGLT, Sotagliflozin, Sodium-dependent glucose cotransporters
Field of Research
Pharmacology & Drug Discovery
Purity
≥95% (May vary between batches)
Solubility
H2O:< 1 mg/mL (insoluble or slightly soluble) ; DMSO:262.5 mg/mL (617.73 mM) ; Ethanol:14 mg/mL (32.95 mM)
Smiles
CCOc1ccc (Cc2cc (ccc2Cl) [C@@H]2O[C@H] (SC) [C@@H] (O) [C@H] (O) [C@H]2O) cc1
Molecular Formula
C21H25ClO5S
Molecular Weight
424.94
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP318556M 100 µg
PDZD6 (INTU) (NM_015693) Human Recombinant Protein
Sign In for Pricing
View Details 
